OTC Markets OTCPK - Delayed Quote USD

Craneware plc (CRWRF)

Compare
23.86 +0.86 (+3.74%)
As of 9:30 AM EDT. Market Open.
Loading Chart for CRWRF
DELL
  • Previous Close 23.00
  • Open 23.86
  • Bid 23.64 x 40000
  • Ask 28.61 x --
  • Day's Range 23.86 - 23.86
  • 52 Week Range 19.01 - 30.00
  • Volume 2,283
  • Avg. Volume 12
  • Market Cap (intraday) 843.277M
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 72.30
  • EPS (TTM) 0.33
  • Earnings Date Sep 3, 2024
  • Forward Dividend & Yield 0.37 (1.37%)
  • Ex-Dividend Date Nov 29, 2024
  • 1y Target Est --

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

www.thecranewaregroup.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CRWRF

View More

Performance Overview: CRWRF

Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRWRF
20.04%
FTSE 100
6.58%

1-Year Return

CRWRF
23.10%
FTSE 100
10.01%

3-Year Return

CRWRF
25.82%
FTSE 100
16.16%

5-Year Return

CRWRF
12.11%
FTSE 100
15.01%

Compare To: CRWRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRWRF

View More

Valuation Measures

Annual
As of 10/9/2024
  • Market Cap

    920.89M

  • Enterprise Value

    926.45M

  • Trailing P/E

    81.93

  • Forward P/E

    25.77

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.07

  • Price/Book (mrq)

    2.93

  • Enterprise Value/Revenue

    4.89

  • Enterprise Value/EBITDA

    17.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.18%

  • Return on Assets (ttm)

    2.28%

  • Return on Equity (ttm)

    3.57%

  • Revenue (ttm)

    189.27M

  • Net Income Avi to Common (ttm)

    11.7M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34.59M

  • Total Debt/Equity (mrq)

    12.22%

  • Levered Free Cash Flow (ttm)

    29.07M

Company Insights: CRWRF

People Also Watch